Key facts
- PROEHL GERALD T filed SCHEDULE 13D/A for Dermata Therapeutics, Inc. Common Stock, Par Value $0.0001 Per Share. (DRMA).
- Disclosed ownership: 17%.
- Date of event: 19 Feb 2026.
PROEHL GERALD T - 19 Feb 2026 SCHEDULE 13D/A Report for Dermata Therapeutics, Inc. Common Stock, Par Value $0.0001 Per Share. (DRMA)
- Filing Manager
- PROEHL GERALD T
- Reporting Manager
- PROEHL GERALD T
- Symbol
- DRMA
- Shares outstanding
- 4,015,532 shares
- Disclosed Ownership
- 694,687 shares
- Ownership
- 17%
- Form type
- SCHEDULE 13D/A
- Filing time
- 23 Feb 2026, 19:56:24 UTC
- Date of event
- 19 Feb 2026
- Previous filing
- 02 Feb 2026
- SEC
- View on sec.gov
Key filing fact
PROEHL GERALD T disclosed 17% ownership in Dermata Therapeutics, Inc. Common Stock, Par Value $0.0001 Per Share. (DRMA) on 19 Feb 2026.
Change
- Previous schedule filing date: 02 Feb 2026.
- Current filing was accepted on 23 Feb 2026, 19:56.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (1)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| PROEHL GERALD T | 17% | 694,687 | 694,687 | 0 | /s/ Gerald T. Proehl | Gerald T. Proehl | 0001279191 |
CIK / CUSIP context first